功能对使用西洛斯塔预防中风的双重抗血小板治疗的影响:CSPS.com试验后期分析
Junpei Koge1, Kazunori Toyoda1, Masatoshi Koga1
1Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
Journal of the neurological sciences
|August 22, 2025
概括
在轻度功能下降的患者中,使用西洛斯塔的双重抗血小板治疗减少了中风复发. 然而,对于正常或严重功能受损的患者来说,它没有益处.
科学领域:
- 神经学
- 肝脏病学
- 药理学
背景情况:
- 对于长期使用西洛斯塔来预防中风的双重抗血小板治疗,功能的影响尚不清楚.
- 研究了估计的血小板过率 (eGFR) 对基于西洛斯塔的双重抗血小板治疗的疗效和安全性的影响.
研究的目的:
- 评估长期用西洛斯塔进行的双重抗血小板治疗对不同水平的功能进行的二次中风预防的疗效和安全性.
- 确定估计的膜过率 (eGFR) 是否会影响与阿司匹林或克洛皮多格雷尔联合使用的西洛斯塔的有效性.
主要方法:
- 一个多中心,开放标签,随机对照试验的后期分析.
- 包括1749名高危非心血管血性中风患者.
- 根据基线EGFR分类的患者:≥90mL/ min/ 1. 73m2 (正常/ 增加),60-89mL/ min/ 1. 73m2 (轻微减少) 和<60mL/ min/ 1. 73m2 (中度减少).
主要成果:
- 与单一治疗相比,在轻微降低EGFR (aHR,0. 35;95% CI,0. 19- 0. 66) 的患者中,使用西洛斯塔的双重治疗显著降低了缺血性中风的复发率.
- 在中风复发中,双疗法和单疗法在中度降低EGFR (aHR,0. 78;0. 34-1. 82) 或正常/增加EGFR (aHR,0. 48;0. 14-1. 64) 的患者中没有显著差异.
结论:
- 在轻度功能下降的患者中,长期双重抗血小板治疗更有效地预防复发性缺血性中风.
- 在中度降低或正常/ 增加功能的患者中,基於西洛斯塔的雙重治療沒有比單一治療更高的效果.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Factors Affecting Renal Clearance: Renal Impairment
157
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
157
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
227
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
227


